Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial α1AMPK
Abstract Sepsis capillary leak syndrome (SCLS) is an independent prognostic factor for poor sepsis outcome. We previously demonstrated that α1AMP-activated protein kinase (α1AMPK) prevents sepsis-induced vascular hyperpermeability by mechanisms involving VE-cadherin (VE-Cad) stabilization and activa...
Guardado en:
Autores principales: | Marine Angé, Julien De Poortere, Audrey Ginion, Sylvain Battault, Mélanie Dechamps, Giulio G. Muccioli, Martin Roumain, Johann Morelle, Sébastien Druart, Thomas Mathivet, Luc Bertrand, Diego Castanares-Zapatero, Sandrine Horman, Christophe Beauloye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dc9c7a02d37340ff943334e7a5f7da61 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
por: Roselle Gélinas, et al.
Publicado: (2018) -
Canagliflozin review – safety and efficacy profile in patients with T2DM
por: Jakher H, et al.
Publicado: (2019) -
Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
por: Nina A. Petunina, et al.
Publicado: (2016) -
Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
por: Fleming JW, et al.
Publicado: (2015) -
Water leak detection based on convolutional neural network using actual leak sounds and the hold-out method
por: Y. W. Nam, et al.
Publicado: (2021)